387 related articles for article (PubMed ID: 15740478)
1. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
[TBL] [Abstract][Full Text] [Related]
2. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
3. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S
J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
[TBL] [Abstract][Full Text] [Related]
5. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
6. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
[TBL] [Abstract][Full Text] [Related]
9. [Primary sclerosing cholangitis and inflammatory bowel disease].
Schrumpf E; Fausa O; Aadland E; Elgjo K; Kolmannskog F
Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1212-6. PubMed ID: 1970674
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
11. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
[TBL] [Abstract][Full Text] [Related]
15. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
16. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
17. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).
Yamamoto-Furusho JK
J Clin Gastroenterol; 2009 Mar; 43(3):221-4. PubMed ID: 19057395
[TBL] [Abstract][Full Text] [Related]
18. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study.
Lundqvist K; Broomé U
Dis Colon Rectum; 1997 Apr; 40(4):451-6. PubMed ID: 9106695
[TBL] [Abstract][Full Text] [Related]
19. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
[TBL] [Abstract][Full Text] [Related]
20. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
